PIMREG and follicular lymphoma: In a CatS Y132D transgenic mouse model of follicular lymphoma, they observed increased cancer growth versus wild-type controls and an increase of the tumor-suppressive CD4+ Treg over cytotoxic CD8+ T cells infiltrating the tumor [1].